Private equity firm Warburg Pincus LLC is to sell 2.77 million shares of portfolio company China Biologic Products in a partial exit, according to a company announcement. Based on the last closing price of the NASDAQ-listed company at US$111 apiece, the sale could yield US$321 million in total, though this type of large share sales […]

Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.